机译:亚洲XELIRIrnProjecT(AXEPT)的研究方案:一项针对转移性结直肠癌的二线化疗的跨国,随机,非劣效,III期临床试验,比较有或无贝伐单抗与有或无贝伐单抗的FOLFIRIrn的疗效和安全性
Gastrointestinal Cancer Center, Sano Hospital, Hyogo 655-0031, Japan;
Department of Surgery, Tokyo Metropolitan Komagome Hospital, Tokyo 113-8677, Japan;
Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka 411-8777, Japan;
Department of Internal Medicine, Seoul National University Hospital, Seoul 110-744, South Korea;
Department of Gastrointestinal Oncology, The First People’s Hospital of Foshan, Foshan, Guangdong 528000, P. R. China;
Department of Internal Medicine, Yonsei University College of Medicine, Seoul 120-752, South Korea;
Department of Medical Oncology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, P. R. China;
Department of Hematology-Oncology, Chonnam National University Medical School, Gwangju 519-809, South Korea;
Department of Digestive Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P. R. China;
Department of Internal Medicine, Seoul National University Bundang HospitalSeoul National University College of Medicine, Seongnam 463-707, South Korea;
Department of Medical Oncology, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P. R. China;
State Key Laboratory of Oncology in South China, Department of Medical Oncology, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P. R. China;
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan;
International Drug Development Institute, Louvain-La-Neuve 1340, Belgium;
Department of Oncology, Asan Medical Center, University of Ulsan Collage of Medicine, Seoul 138-736, South Korea;
Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing 100-142, P. R. China;
Tokai Central Hospital, Kakamigahara 504-8601, Japan;
Department of Oncology, Asan Medical Center, University of Ulsan Collage of Medicine, Seoul 138-736, South Korea;
Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan;
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, South Korea;
Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan;
Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo 104-0045, Japan;
Department of Surgical Specialties, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8519, Japan;
Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama 791-0280, Japan;
Department of Surgical Oncology, The University of Tokyo, Tokyo 113-0033, Japan;